2026 Artemetrx State of Specialty Spend and Trend Report
PSG announces the results of the industry’s go-to report on specialty drug spend and trend. With specialty drug costs remaining a top concern…
Read Post
Insights
Categories
Topics
Categories
Topics
CMS To Recalculate 2024 Medicare Star Ratings
CMS recalculating Star Ratings drives health plans to action. On June 13, 2024, Centers for Medicare and Medicaid Services (CMS) issued a memo outlining…
Read Post
2024 State of Specialty Spend and Trend Report Webinar
PSG announces the results of the industry’s go-to report on specialty spend and trend. Watch industry experts Renee Rayburg, RPh, and Jennifer Warren,…
Read Post
Navigating M3P: Understanding the Essentials and Key Steps for Managed Care Preparation
The Medicare Prescription Payment Plan (M3P) demands immediate action from managed care plans. This aspect of the new Medicare Part…
Read Post
PSG Publishes Annual Drug Benefit Design Report for 2024
DALLAS, TX – June 11, 2024 – Pharmaceutical Strategies Group (“PSG”), an EPIC company, released its annual Trends in Drug Benefit…
Read Post
2024 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges as…
Read Post
Managing Pharmacy Costs with Integrated Data: The Playbook for Plan Sponsors
Plan sponsors face an increasingly complex challenge: effectively managing the high costs of innovative and life-changing medications while providing appropriate treatments for their employees…
Read Post
PBM Moves Spur Humira Biosimilar Uptake but Raise Questions
Reprinted with AIS Health permission from the May 2024 issue of Radar on Specialty Pharmacy. The FDA has approved 10 biosimilars of AbbVie…
Read Post
Report Finds Payers’ Biosimilars Strategies in Flux in a Rapidly Shifting Landscape
Gain insights into biosimilar strategies from our 2024 Trends in Specialty Drug Benefits Report On April 29th, we released our highly anticipated 2024…
Read Post
Payers Continue to Employ Array of Specialty Drug Management Strategies
Reprinted with AIS Health permission from the May 2024 issue of Radar on Specialty Pharmacy. Rebates continue to be a huge part of…
Read Post
Reviewing CMS Draft Guidance for the Medicare Drug Price Negotiation Program (Updated May 2024)
Medicare drug price negotiation, impacts and considerations for plans Several months ago, I wrote a blog about the Medicare Drug…
Read Post
Exploring Diabetes Management with GLP-1s and More
GLP-1s Are Effective Solutions For Managing Diabetes, But Are Only One Piece of the Puzzle With all the talk about GLP-1s for weight loss,…
Read Post